These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2475258)
1. Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen. Mangeney M; Fischer A; Le Deist F; Latgé JP; Durandy A Cell Immunol; 1989 Sep; 122(2):329-37. PubMed ID: 2475258 [TBL] [Abstract][Full Text] [Related]
2. Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes. Durandy A; Fischer A; Griscelli C J Clin Invest; 1983 Jun; 71(6):1602-13. PubMed ID: 6345586 [TBL] [Abstract][Full Text] [Related]
3. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. Podzorski RP; Gray GR; Nelson RD J Immunol; 1990 Jan; 144(2):707-16. PubMed ID: 2153174 [TBL] [Abstract][Full Text] [Related]
4. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. Durandy A; Fischer A; Le Deist F; Drouhet E; Griscelli C J Clin Immunol; 1987 Sep; 7(5):400-9. PubMed ID: 2958495 [TBL] [Abstract][Full Text] [Related]
5. Detection of Candida sp. mannan antigen by indirect ELISA-inhibition. In vitro crossed reactivity among mannans obtained from C. albicans A, C. albicans B, and C. tropicalis. Garcia-de-Lomas J; Morales C; Grau MA; Mir A Mycopathologia; 1988 Jun; 102(3):175-8. PubMed ID: 3050526 [TBL] [Abstract][Full Text] [Related]
6. Candida albicans: mannan and protein activation of cells from various human lymphoid organs. Tollemar J; Ringdén O; Holmberg K Scand J Immunol; 1989 Oct; 30(4):473-80. PubMed ID: 2683035 [TBL] [Abstract][Full Text] [Related]
7. Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis. Kosonen J; Rantala A; Little CH; Lintu P; Harjamäki PR; Georgiou GM; Cone RE; Savolainen J Clin Vaccine Immunol; 2006 Apr; 13(4):467-74. PubMed ID: 16603614 [TBL] [Abstract][Full Text] [Related]
8. Specific in vitro anti-mannan antibody production by human blood lymphocytes. Durandy A; Fischer A; Griscelli C Birth Defects Orig Artic Ser; 1983; 19(3):41-5. PubMed ID: 6360245 [No Abstract] [Full Text] [Related]
9. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Miyakawa Y; Kuribayashi T; Kagaya K; Suzuki M; Nakase T; Fukazawa Y Infect Immun; 1992 Jun; 60(6):2493-9. PubMed ID: 1375200 [TBL] [Abstract][Full Text] [Related]
10. Antigenic relationship between Candida parapsilosis and Candida albicans serotype B. Funayama M; Nishikawa A; Shinoda T; Suzuki M; Fukazawa Y Microbiol Immunol; 1984; 28(12):1359-71. PubMed ID: 6085394 [TBL] [Abstract][Full Text] [Related]
11. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Fischer A; Pichat L; Audinot M; Griscelli C Clin Exp Immunol; 1982 Mar; 47(3):653-60. PubMed ID: 6211308 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. Jones JM J Lab Clin Med; 1980 Nov; 96(5):845-60. PubMed ID: 6999104 [No Abstract] [Full Text] [Related]
13. Synthesis of 3,6-branched oligomannoside fragments of the mannan from Candida albicans cell wall corresponding to the antigenic factor 4. Karelin AA; Tsvetkov YE; Paulovicová L; Bystrický S; Paulovicová E; Nifantiev NE Carbohydr Res; 2010 Jul; 345(10):1283-90. PubMed ID: 20096401 [TBL] [Abstract][Full Text] [Related]
14. Specific binding of antigen onto human T lymphocytes. Durandy A; Fischer A; Charron D; Griscelli C J Clin Invest; 1986 May; 77(5):1557-64. PubMed ID: 3084561 [TBL] [Abstract][Full Text] [Related]
15. Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis. Little CH; Georgiou GM; Marceglia A; Ogedgebe H; Cone RE; Mazza D Infect Immun; 2000 Jul; 68(7):3840-7. PubMed ID: 10858192 [TBL] [Abstract][Full Text] [Related]
16. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro. Kosonen J; Luhtala M; Viander M; Kalimo K; Terho EO; Savolainen J Exp Dermatol; 2005 Jul; 14(7):551-8. PubMed ID: 15946244 [TBL] [Abstract][Full Text] [Related]
17. Differential dendritic cell responses to cell wall mannan of Candida albicans, Candida parapsilosis, and Candida dubliniensis. Nguyen TNY; Matangkasombut O; Ritprajak P J Oral Sci; 2018 Dec; 60(4):557-566. PubMed ID: 30429436 [TBL] [Abstract][Full Text] [Related]
18. A further characterization of Candida albicans-induced suppressor B-cell activity. Cuff CF; Packer BJ; Rogers TJ Immunology; 1989 Sep; 68(1):80-6. PubMed ID: 2530158 [TBL] [Abstract][Full Text] [Related]
19. Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans. Gettner SM; Mackenzie DW J Med Microbiol; 1981 Aug; 14(3):333-40. PubMed ID: 7021839 [TBL] [Abstract][Full Text] [Related]
20. Restriction of the in vitro anti-mannan antibody response by HLA-DQ molecules. Durandy A; Fischer A; Charron DJ; Griscelli C Hum Immunol; 1986 May; 16(1):114-25. PubMed ID: 3486860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]